To display a list of Bing Center Newsletters, please visit our Newsletter Archive.

Title Created Date
Should Patients Pay to Play? 16 November 2015
Running for Dana-Farber: Dr. Edward Laane 25 August 2015
Meet Josephine Vos, MD 08 July 2015
European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat Waldenstrom's Macroglobulinemia 09 June 2015
Running for Waldenstrom's (part 2) 04 May 2015
2015 IWMF Educational Forum 04 May 2015
What It's Like to Enroll in a Clinical Trial 04 May 2015
2014 ASH Exposition and Conference 04 May 2015
Running for Waldenstrom's - Sandra Kanan 04 May 2015
Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for Waldenstrom's Macroglobulinemia 04 May 2015
U.S. FDA Approves IMBRUVICA® (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia 01 May 2015
8th International Workshop on WM 11 September 2014
Clinical Study for Carfilzomib, Dexamethasone and Rituximab (CARD) reported in BLOOD 19 May 2014
Dr. Treon presents findings from the whole genome sequencing project at the Annual Meeting of the International Waldenstrom’s Macroglobulinemia Foundation in Tampa, FL 17 May 2014
Study by the Bing Center shows Improving Survival Trends for WM 12 May 2014
Zachary Hunter and Steve Treon deliver addresses at the IWMF Canada Annual Meeting in Vancouver BC 05 April 2014
Dr. Treon addresses the Clinical Advisory Committee of the World Health Organization (WHO) in Chicago, IL 31 March 2014
National Comprehensive Cancer Network (NCCN) adds Ibrutinib to the list of therapies for WM patients with relapsed or refractory WM 08 January 2014
ASH 2013 Attendees 17 December 2013
ASH 2013 Annual Meeting and Exposition 12 December 2013